0001209191-19-018632.txt : 20190311 0001209191-19-018632.hdr.sgml : 20190311 20190311202125 ACCESSION NUMBER: 0001209191-19-018632 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190301 FILED AS OF DATE: 20190311 DATE AS OF CHANGE: 20190311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Karrmann Sandra R CENTRAL INDEX KEY: 0001354100 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 19673697 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE, SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2019-03-01 0 0000070318 TENET HEALTHCARE CORP THC 0001354100 Karrmann Sandra R 1445 ROSS AVENUE SUITE 1400 DALLAS TX 75202 0 1 0 0 EVP and Chief HR Officer Common Stock 2971 D 2018 February Restricted Stock Units Common Stock 8091 D 2018 February Performance Stock Options (Right to Buy) 20.60 2028-02-28 Common Stock 28313 D 2019 February Restricted Stock Units Common Stock 9437 D 2019 February Performance Stock Options (Right to Buy) 28.26 2029-02-27 Common Stock 21351 D Half of these time-based restricted stock units vest on each of February 28, 2020 and 2021. Restricted stock units are settled in shares of the Company's common stock upon vesting. These performance-based stock options will vest on February 28, 2021, as the stock price performance condition has been satisfied. One-third of these time-based restricted stock units vest on each of February 27, 2020, 2021 and 2022. These performance-based stock options vest on February 27, 2022, subject to the satisfaction of a stock price performance condition requiring the Company's common stock price to close at or above $35.33 per share for any 20 consecutive trading days during the three-year period following the date of grant, which was February 27, 2019. Anthony L. Shoemaker, as Attorney-in-Fact for Sandra R. Karrmann 2019-03-11 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY

        Know all by these presents that the undersigned hereby constitutes
and appoints each of Audrey T. Andrews, Mark R. Jackson, Kristina A. Mack and
Anthony L. Shoemaker, signing singly, the undersigned's true and lawful
attorney-in-fact to:

(1)     prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC")
a Form ID, including amendments thereto, and any other documents necessary or
appropriate to obtain codes and passwords enabling the undersigned to make
electronic filings with the SEC of reports required by Section 16(a) of the
Securities Exchange Act of 1934 (the "Exchange Act") or any rule or regulation
of the SEC;

(2)     execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer of Tenet Healthcare Corporation (the "Company"),
Forms 3, 4 and 5 in accordance with Section 16(a) of the Exchange Act and the
rules and regulations thereunder, and any other forms or reports the
undersigned may be required to file in connection with the undersigned's
ownership, acquisition or disposition of securities of the Company;

(3)     do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to complete and execute any such Form 3,
4 or 5, or other form or report, and timely file such form or report with the
SEC and any stock exchange or similar authority; and

(4)     take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in his or
her discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or his or her substitute or substitutes, shall lawfully do
or cause to be done by virtue of this Power of Attorney and the rights and
powers herein granted.  The undersigned acknowledges that the foregoing
attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming any of the undersigned's responsibilities to
comply with Section 16 of the Exchange Act.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 5th day of March, 2019.


                                                      /s/ Sandra R. Karrmann
                                                      Sandra R. Karrmann